Showing 2,387 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Pharmaceutical industry

Merck (MRK) Receives Positive CHMP Opinion for Dutrebis as HIV 1 Treatment

Editor's pick
Street Insider
26 January 2015
Cancer

Low CD4 count, suboptimal HIV treatment linked to higher anal cancer risk

Editor's pick
HIVandHepatitis.com
23 January 2015
Resistance

Exploring possible treatment options after virological failure with raltegravir

Editor's pick
CATIE
21 January 2015
New & experimental HIV treatments

New anti HIV drug dolutegravir is effective at low doses

Editor's pick
MMD Newswire
21 January 2015
Pregnancy and vertical transmission

HIV—Pregnancy-related issues

Editor's pick
CATIE
20 January 2015
Side effects

Zimbabwe finally switches away from stavudine

Editor's pick
AllAfrica
19 January 2015
Cardiovascular disease

Dramatic decline in risk for heart attacks among HIV-positive Kaiser Permanente members

Editor's pick
Eurekalert
19 January 2015
PrEP

Drug Resistance, While Rare, Can Occur After Contracting HIV on PrEP

Editor's pick
AIDSMeds
16 January 2015
Access to healthcare

Hepatitis C drug delayed by NHS due to high cost

Editor's pick
The Guardian
16 January 2015
New & experimental HIV treatments

Janssen launches HIV combo Rezolsta in UK

Editor's pick
Pharma Times
15 January 2015
Treatment guidelines

Dolutegravir and Truimeq approved in England: London guidelines updated

Editor's pick
HIV i-Base
14 January 2015
Starting treatment

Study uncovers new ground about when to start HIV therapy

Editor's pick
CATIE
13 January 2015
Treatment guidelines

Dolutegravir/abacavir/lamivudine: considerable added benefit for treatment-naive adults with HIV

Editor's pick
The Institute for Quality and Efficiency in Health Care
12 January 2015
New & experimental HIV treatments

Argos tanks as its HIV immunotherapy flunks Phase II

Editor's pick
FierceBiotech
12 January 2015
Starting treatment

First Year After HIV Infection Is Key Window for Treatment Start

Editor's pick
AIDSMeds
7 January 2015
Treatment guidelines

Zimbabwe: Govt introduces new HIV treatment

Editor's pick
NewZimbabwe.com
7 January 2015
Pharmaceutical industry

Gilead, Janssen Expand HIV Combo Collaborations

Editor's pick
Genetic Engineering & Biotechnology News
30 December 2014
Pharmaceutical industry

Gilead Sciences, Inc. Can't Do It Alone

Editor's pick
Motley Fool
30 December 2014
Resistance

Drug-resistant infections could lead to 10 million extra deaths a year – report

Editor's pick
The Guardian
11 December 2014
HIV prevention policy

How San Francisco Is Getting to Zero On HIV

Editor's pick
Huffington Post
11 December 2014
Bad science & bogus treatments

Preventing bad reporting on health research

Editor's pick
BMJ
10 December 2014
Health monitoring in resource-limited settings

Sophisticated HIV diagnostics adapted for remote areas

Editor's pick
Science Daily
10 December 2014
Ageing & HIV

HIV-infected adults diagnosed with age-related diseases at similar ages as uninfected adults

Editor's pick
Science Daily
10 December 2014
Bad science & bogus treatments

Is HIV Weakening Over Time?

Editor's pick
TAG
3 December 2014